Fundraising Fox

J. Matthew Mackowski

Investor

Chairman, Managing Director at Telegraph Hill Partners · Board director at Emerging Therapy Solutions

San Francisco

About

A healthcare-focused venture capital investor since 1980 who began at Citicorp Venture Capital and founded Mackowski & Shepler in 1991, the predecessor to Telegraph Hill Partners. He has served on numerous portfolio company boards including Althea Technologies, Ambion, Asuragen, and Teknova.

Contact· self-published, not guessed

Invests in

BiotechHealthtechMedical Devices

Board director at Emerging Therapy Solutions

Intro paths

In turn, J. can intro founders to Emerging Therapy Solutions's investors below.

Investments

Board seats

Althea TechnologiesAmbionAsuragenEmerging Therapy SolutionsInterface AssociatesKinetikos MedicalMagstimMedPricerNimble TherapeuticsTeknovaTrakCel

Per the firm's website.

Colleagues at Telegraph Hill Partners

Frequently asked questions

Who is J. Matthew Mackowski?
A healthcare-focused venture capital investor since 1980 who began at Citicorp Venture Capital and founded Mackowski & Shepler in 1991, the predecessor to Telegraph Hill Partners. He has served on numerous portfolio company boards including Althea Technologies, Ambion, Asuragen, and Teknova.
Where does J. Matthew Mackowski work?
J. Matthew Mackowski is Chairman, Managing Director at Telegraph Hill Partners and Board director at Emerging Therapy Solutions.
What does J. Matthew Mackowski invest in?
J. Matthew Mackowski invests in Biotech, Healthtech, Medical Devices.
What boards does J. Matthew Mackowski sit on?
J. Matthew Mackowski holds tracked board seats at Althea Technologies, Ambion, Asuragen, Emerging Therapy Solutions, Interface Associates, Kinetikos Medical, Magstim, MedPricer, Nimble Therapeutics, Teknova.